184 related articles for article (PubMed ID: 29375670)
1. Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.
Smetana J; Oppelt J; Štork M; Pour L; Kuglík P
Mol Cytogenet; 2018; 11():7. PubMed ID: 29375670
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myeloma.
Kaur G; Gupta R; Mathur N; Rani L; Kumar L; Sharma A; Singh V; Gupta A; Sharma OD
Leuk Res; 2019 Jan; 76():58-64. PubMed ID: 30576858
[TBL] [Abstract][Full Text] [Related]
3. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
[TBL] [Abstract][Full Text] [Related]
4. Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singapore.
Lim AS; Krishnan S; Lim TH; See K; Ng YJ; Tan YM; Choo N; Lau LC; Tien SL; Ma J; Tan D
Indian J Hematol Blood Transfus; 2014 Dec; 30(4):253-8. PubMed ID: 25435723
[TBL] [Abstract][Full Text] [Related]
5. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
[TBL] [Abstract][Full Text] [Related]
6. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.
Smetana J; Frohlich J; Zaoralova R; Vallova V; Greslikova H; Kupska R; Nemec P; Mikulasova A; Almasi M; Pour L; Adam Z; Sandecka V; Zahradová L; Hajek R; Kuglik P
Biomed Res Int; 2014; 2014():209670. PubMed ID: 24987674
[TBL] [Abstract][Full Text] [Related]
8. Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma.
Hirsch D; Kemmerling R; Davis S; Camps J; Meltzer PS; Ried T; Gaiser T
Cancer Res; 2013 Mar; 73(5):1454-60. PubMed ID: 23271725
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics in multiple myeloma patients progressing into extramedullary disease.
Besse L; Sedlarikova L; Greslikova H; Kupska R; Almasi M; Penka M; Jelinek T; Pour L; Adam Z; Kuglik P; Krejci M; Hajek R; Sevcikova S
Eur J Haematol; 2016 Jul; 97(1):93-100. PubMed ID: 26432667
[TBL] [Abstract][Full Text] [Related]
10. Revealing the impact of structural variants in multiple myeloma.
Rustad EH; Yellapantula VD; Glodzik D; Maclachlan KH; Diamond B; Boyle EM; Ashby C; Blaney P; Gundem G; Hultcrantz M; Leongamornlert D; Angelopoulos N; Agnelli L; Auclair D; Zhang Y; Dogan A; Bolli N; Papaemmanuil E; Anderson KC; Moreau P; Avet-Loiseau H; Munshi NC; Keats JJ; Campbell PJ; Morgan GJ; Landgren O; Maura F
Blood Cancer Discov; 2020 Nov; 1(3):258-273. PubMed ID: 33392515
[TBL] [Abstract][Full Text] [Related]
11. Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.
Nemec P; Zemanova Z; Greslikova H; Michalova K; Filkova H; Tajtlova J; Kralova D; Kupska R; Smetana J; Krejci M; Pour L; Zahradova L; Sandecka V; Adam Z; Buchler T; Spicka I; Gregora E; Kuglik P; Hajek R
Biol Blood Marrow Transplant; 2010 Apr; 16(4):548-54. PubMed ID: 20005965
[TBL] [Abstract][Full Text] [Related]
12. Structural variants shape the genomic landscape and clinical outcome of multiple myeloma.
Ashby C; Boyle EM; Bauer MA; Mikulasova A; Wardell CP; Williams L; Siegel A; Blaney P; Braunstein M; Kaminetsky D; Keats J; Maura F; Landgren O; Walker BA; Davies FE; Morgan GJ
Blood Cancer J; 2022 May; 12(5):85. PubMed ID: 35637217
[TBL] [Abstract][Full Text] [Related]
13. Complex X-Chromosomal Rearrangements in Two Women with Ovarian Dysfunction: Implications of Chromothripsis/Chromoanasynthesis-Dependent and -Independent Origins of Complex Genomic Alterations.
Suzuki E; Shima H; Toki M; Hanew K; Matsubara K; Kurahashi H; Narumi S; Ogata T; Kamimaki T; Fukami M
Cytogenet Genome Res; 2016; 150(2):86-92. PubMed ID: 28099951
[TBL] [Abstract][Full Text] [Related]
14. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
[TBL] [Abstract][Full Text] [Related]
15. Genomic Chaos (Multiple Copy Number Variations and Structural Reorganization) Detected in Two Prenatal Cases.
Lloveras E; Canellas A; Plaja A; Barranco L; Fernández D; Mendez B; Piqué M; de la Iglesia C; Palau N; Costa M; Herrero M; Yeste D; Auge M; Puig L; Pérez C
Cytogenet Genome Res; 2021; 161(5):236-242. PubMed ID: 34274931
[TBL] [Abstract][Full Text] [Related]
16. A CGH array study in nonsyndromic (primary) autism patients: deletions on 16p13.11, 16p11.2, 1q21.1, 2q21.1q21.2, and 8p23.1.
Gümüşlü KE; Savli H; Sünnetçi D; Çine N; Kara B; Eren Keskin S; Akkoyunlu RU
Turk J Med Sci; 2015; 45(2):313-9. PubMed ID: 26084120
[TBL] [Abstract][Full Text] [Related]
17. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
Bochtler T; Granzow M; Stölzel F; Kunz C; Mohr B; Kartal-Kaess M; Hinderhofer K; Heilig CE; Kramer M; Thiede C; Endris V; Kirchner M; Stenzinger A; Benner A; Bornhäuser M; Ehninger G; Ho AD; Jauch A; Krämer A;
Blood; 2017 Mar; 129(10):1333-1342. PubMed ID: 28119329
[TBL] [Abstract][Full Text] [Related]
18. Defining the limits of detection for chromosome rearrangements in the preimplantation embryo using next generation sequencing.
Cuman C; Beyer CE; Brodie D; Fullston T; Lin JI; Willats E; Zander-Fox D; Mullen J
Hum Reprod; 2018 Aug; 33(8):1566-1576. PubMed ID: 30007310
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Chromothripsis by Combined FISH and Microarray Analysis.
MacKinnon RN
Methods Mol Biol; 2018; 1769():53-77. PubMed ID: 29564818
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.
Minguela A; Vasco-Mogorrón MA; Campillo JA; Cabañas V; Remigia MJ; Berenguer M; García-Garay MC; Blanquer M; Cava C; Galian JA; Gimeno L; Soto-Ramírez MF; Martínez-Hernández MD; de la Rubia J; Teruel AI; Muro M; Periago A
Am J Cancer Res; 2021; 11(9):4438-4454. PubMed ID: 34659897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
